Detecting low frequency mutations poses a significant challenge due to their rarity. Advanced techniques such as next-generation sequencing (NGS), digital droplet PCR (ddPCR), and single-cell sequencing are employed to identify these mutations with high sensitivity and specificity. These technologies can uncover mutations that traditional methods might miss, enabling a more comprehensive understanding of the tumor's genetic landscape.
